Endocannabinoid signaling in the amygdala: Anatomy, synaptic signaling, behavior, and adaptations to stress

Neuroscience

Volumn 204, Issue , 2012, Pages 38-52

  Ramikie, T S ^a   Patel, S ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anatomy; Anxiety; Cannabis; CB1 receptor; Fear conditioning; Marijuana

Indexed keywords

ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; LIPOPROTEIN LIPASE;

ADAPTATION; AMYGDALOID NUCLEUS; BASOLATERAL AMYGDALA; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; CENTRAL NUCLEUS (AMYGDALA); GABAERGIC TRANSMISSION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; IN VIVO STUDY; NERVE CELL PLASTICITY; NEUROANATOMY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STRESS; SYNAPTIC TRANSMISSION;

ADAPTATION, PHYSIOLOGICAL; ADAPTATION, PSYCHOLOGICAL; AMYGDALA; ANIMALS; BEHAVIOR, ANIMAL; ENDOCANNABINOIDS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SYNAPSES;

EID: 84857126583     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.08.037     Document Type: Review

References (93)

1. Ahn K., McKinney M.K., Cravatt B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 2008, 108:1687-1707.
2. Alvarez-Jaimes L., Polis I., Parsons L.H. Attenuation of cue-induced heroin-seeking behavior by cannabinoid CB1 antagonist infusions into the nucleus accumbens core and prefrontal cortex, but not basolateral amygdala. Neuropsychopharmacology 2008, 33:2483-2493.
3. Amano T., Unal C.T., Paré D. Synaptic correlates of fear extinction in the amygdala. Nat Neurosci 2010, 13:489-494.
4. Auclair N., Otani S., Soubrie P., Crepel F. Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons. J Neurophysiol 2000, 83:3287-3293.
5. Azad S.C., Eder M., Marsicano G., Lutz B., Zieglgänsberger W., Rammes G. Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse. Learn Mem 2003, 10:116-128.
6. Azad S.C., Kurz J., Marsicano G., Lutz B., Zieglgänsberger W., Rammes G. Activation of CB1 specifically located on GABAergic interneurons inhibits LTD in the lateral amygdala. Learn Mem 2008, 15:143-152.
7. Azad S.C., Monory K., Marsicano G., Cravatt B.F., Lutz B., Zieglgänsberger W., Rammes G. Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling. J Neurosci 2004, 24:9953-9961.
8. Bisogno T., Howell F., Williams G., Minassi A., Cascio M.G., Ligresti A., Matias I., Schiano-Moriello A., Paul P., Williams E.J., Gangadharan U., Hobbs C., Di Marzo V., Doherty P. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 2003, 163:463-468.
9. Blankman J.L., Simon G.M., Cravatt B.F. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 2007, 14:1347-1356.
10. Bodor A.L., Katona I., Nyíri G., Mackie K., Ledent C., Hájos N., Freund T.F. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 2005, 25:6845-6856.
11. Bracey M.H., Hanson M.A., Masuda K.R., Stevens R.C., Cravatt B.F. Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 2002, 298:1793-1796.
12. Cassell M.D., Freedman L.J., Shi C. The intrinsic organization of the central extended amygdala. Ann N Y Acad Sci 1999, 877:217-241.
13. Chevaleyre V., Heifets B.D., Kaeser P.S., Südhof T.C., Castillo P.E. Endocannabinoid-mediated long-term plasticity requires cAMP/PKA signaling and RIM1alpha. Neuron 2007, 54:801-812.
14. Chevaleyre V., Takahashi K.A., Castillo P.E. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Review Neurosci 2006, 29:37-76.
15. Chhatwal J.P., Davis M., Maguschak K.A., Ressler K.J. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology 2005, 30:516-524.
16. Ciocchi S., Herry C., Grenier F., Wolff S.B., Letzkus J.J., Vlachos I., Ehrlich I., Sprengel R., Deisseroth K., Stadler M.B., Müller C., Lüthi A. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 2010, 468:277-282.
17. Connell K., Bolton N., Olsen D., Piomelli D., Hohmann A.G. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia. Neurosci Lett 2006, 397:180-184.
18. Cravatt B.F., Lichtman A.H. The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem Phys Lipids 2002, 121:135-148.
19. Davis M. Neurobiology of fear responses: the role of the amygdala. J Neuropsychiatry Clin Neurosci 1997, 9:382-402.
20. Davis M., Whalen P.J. The amygdala: vigilance and emotion. Mol Psychiatry 2001, 6:13-34.
21. Di Marzo V., De Petrocellis L., Bisogno T. The biosynthesis, fate and pharmacological properties of endocannabinoids. Handb Exp Pharmacol 2005, 168:147-185.
22. Dinh T.P., Carpenter D., Leslie F.M., Freund T.F., Katona I., Sensi S.L., Kathuria S., Piomelli D. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 2002, 99:10819-10824.
23. Dinh T.P., Freund T.F., Piomelli D. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids 2002, 121:149-158.
24. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., Zieglgänsberger W., Lutz B., Rammes G. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 2006, 26:5794-5799.
25. Egertová M., Cravatt B.F., Elphick M.R. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 2003, 119:481-496.
26. Eggan S.M., Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 2007, 17:175-191.
27. Engler B., Freiman I., Urbanski M., Szabo B. Effects of exogenous and endogenous cannabinoids on GABAergic neurotransmission between the caudate-putamen and the globus pallidus in the mouse. J Pharmacol Exp Ther 2006, 316:608-617.
28. Ganon-Elazar E., Akirav I. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J Neurosci 2009, 29:11078-11088.
29. Gerdeman G., Lovinger D.M. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 2001, 85:468-471.
30. Gulyas A.I., Cravatt B.F., Bracey M.H., Dinh T.P., Piomelli D., Boscia F., Freund T.F. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 2004, 20:441-458.
31. Hasanein P., Parviz M., Keshavarz M., Javanmardi K. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception. Clin Exp Pharmacol Physiol 2007, 34:439-449.
32. Hashimotodani Y., Ohno-Shosaku T., Kano M. Endocannabinoids and synaptic function in the CNS. Neuroscientist 2007, 13:127-137.
33. Heifets B.D., Castillo P.E. Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol 2009, 71:283-306.
34. Hermann H., Lutz B. Coexpression of the cannabinoid receptor type 1 with the corticotropin-releasing hormone receptor type 1 in distinct regions of the adult mouse forebrain. Neurosci Lett 2005, 375:13-18.
35. Hermann H., Marsicano G., Lutz B. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 2002, 109:451-460.
36. Hill E.L., Gallopin T., Férézou I., Cauli B., Rossier J., Schweitzer P., Lambolez B. Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol 2007, 97:2580-2589.
37. Hill M.N., Carrier E.J., McLaughlin R.J., Morrish A.C., Meier S.E., Hillard C.J., Gorzalka B.B. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem 2008, 106:2322-2336.
38. Hill M.N., Ho W.S., Meier S.E., Gorzalka B.B., Hillard C.J. Chronic corticosterone treatment increases the endocannabinoid 2-arachidonylglycerol in the rat amygdala. Eur J Pharmacol 2005, 528:99-102.
39. Hill M.N., Karatsoreos I.N., Hillard C.J., McEwen B.S. Rapid elevations in limbic endocannabinoid content by glucocorticoid hormones in vivo. Psychoneuroendocrinology 2010, 35:1333-1338.
40. Hill M.N., McLaughlin R.J., Bingham B., Shrestha L., Lee T.T., Gray J.M., Hillard C.J., Gorzalka B.B., Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proc Natl Acad Sci U S A 2010, 107:9406-9411.
41. Hill M.N., McLaughlin R.J., Morrish A.C., Viau V., Floresco S.B., Hillard C.J., Gorzalka B.B. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Neuropsychopharmacology 2009, 34:2733-2745.
42. Huang Y.C., Wang S.J., Chiou L.C., Gean P.W. Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala. J Neurosci 2003, 23:10311-10320.
43. Kamprath K., Romo-Parra H., Häring M., Gaburro S., Doengi M., Lutz B., Pape H.C. Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdala. Neuropsychopharmacology 2011, 36:652-663.
44. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 2009, 89:309-380.
45. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., Freund T.F. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001, 21:9506-9518.
46. Knapska E., Radwanska K., Werka T., Kaczmarek L. Functional internal complexity of amygdala: focus on gene activity mapping after behavioral training and drugs of abuse. Physiol Rev 2007, 87:1113-1173.
47. Kodirov S.A., Jasiewicz J., Amirmahani P., Psyrakis D., Bonni K., Wehrmeister M., Lutz B. Endogenous cannabinoids trigger the depolarization-induced suppression of excitation in the lateral amygdala. Learn Mem 2009, 17:43-49.
48. Lafourcade M., Elezgarai I., Mato S., Bakiri Y., Grandes P., Manzoni O.J. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS ONE 2007, 2:e709.
49. Laviolette S.R., Grace A.A. Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs. J Neurosci 2006, 26:6458-6468.
50. Laviolette S.R., Grace A.A. The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction. Cell Mol Life Sci 2006, 63:1597-1613.
51. Long J.Z., Li W., Booker L., Burston J.J., Kinsey S.G., Schlosburg J.E., Pavón F.J., Serrano A.M., Selley D.E., Parsons L.H., Lichtman A.H., Cravatt B.F. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol 2009, 5:37-44.
52. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 1992, 48:655-668.
53. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 1999, 11:4213-4225.
54. Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglgänsberger W., Di Marzo V., Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature 2002, 418:530-534.
55. Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 1993, 327:535-550.
56. McDonald A.J. Is there an amygdala and how far does it extend?. An anatomical perspective. Ann N Y Acad Sci 2003, 985:1-21.
57. McDonald A.J., Mascagni F. Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons. Neuroscience 2001, 107:641-652.
58. Milad M.R., Quirk G.J. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002, 420:70-74.
59. Morales M., Bäckman C. Coexistence of serotonin 3 (5-HT3) and CB1 cannabinoid receptors in interneurons of hippocampus and dentate gyrus. Hippocampus 2002, 12:756-764.
60. Morales M., Wang S.D., Diaz-Ruiz O., Jho D.H. Cannabinoid CB1 receptor and serotonin 3 receptor subunit A (5-HT3A) are co-expressed in GABA neurons in the rat telencephalon. J Comp Neurol 2004, 468:205-216.
61. Onaivi E.S., Chakrabarti A., Gwebu E.T., Chaudhuri G. Neurobehavioral effects of delta 9-THC and cannabinoid (CB1) receptor gene expression in mice. Behav Brain Res 1995, 72:115-125.
62. Ong W.Y., Mackie K. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 1999, 92:1177-1191.
63. Pape H.C., Pare D. Plastic synaptic networks of the amygdala for the acquisition, expression, and extinction of conditioned fear. Physiol Rev 2010, 90:419-463.
64. Paré D., Quirk G.J., Ledoux J.E. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004, 92:1-9.
65. Patel S., Hillard C.J. Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation. Eur J Neurosci 2008, 27:2821-2829.
66. Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
67. Patel S., Roelke C.T., Rademacher D.J., Cullinan W.E., Hillard C.J. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 2004, 145:5431-5438.
68. Patel S., Roelke C.T., Rademacher D.J., Hillard C.J. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur J Neurosci 2005, 21:1057-1069.
69. Perra S., Pillolla G., Melis M., Muntoni A.L., Gessa G.L., Pistis M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacol Berl 2005, 183:368-377.
70. Pertwee R.G. Pharmacological actions of cannabinoids. Handbook of experimental pharmacology 2005, 1-51.
71. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev 2003, 4:873-884.
72. Pistis M., Muntoni A.L., Pillolla G., Gessa G.L. Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study. Eur J Neurosci 2002, 15:1795-1802.
73. Pistis M., Perra S., Pillolla G., Melis M., Gessa G.L., Muntoni A.L. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 2004, 46:115-125.
74. Rademacher D.J., Meier S.E., Shi L., Ho W.S., Jarrahian A., Hillard C.J. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 2008, 54:108-116.
75. Rezayof A., Sardari M., Zarrindast M.R., Nayer-Nouri T. Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behav Brain Res 2011, 220:1-8.
76. Roberto M., Cruz M., Bajo M., Siggins G.R., Parsons L.H., Schweitzer P. The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 2010, 35:1962-1972.
77. Roche M., O'Connor E., Diskin C., Finn D.P. The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats. Eur J Neurosci 2007, 26:2643-2653.
78. Royer S., Martina M., Paré D. An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J Neurosci 1999, 19:10575-10583.
79. Rubino T., Guidali C., Vigano D., Realini N., Valenti M., Massi P., Parolaro D. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology 2008, 54:151-160.
80. Sah P., Faber E.S., Lopez De Armentia M., Power J. The amygdaloid complex: anatomy and physiology. Physiol Rev 2003, 83:803-834.
81. Samson R.D., Paré D. A spatially structured network of inhibitory and excitatory connections directs impulse traffic within the lateral amygdala. Neuroscience 2006, 141:1599-1609.
82. Schlosburg J.E., Blankman J.L., Long J.Z., Nomura D.K., Pan B., Kinsey S.G., Nguyen P.T., Ramesh D., Booker L., Burston J.J., Thomas E.A., Selley D.E., Sim-Selley L.J., Liu Q.S., Lichtman A.H., Cravatt B.F. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 2010, 13:1113-1119.
83. Shin R.M., Tully K., Li Y., Cho J.H., Higuchi M., Suhara T., Bolshakov V.Y. Hierarchical order of coexisting pre- and postsynaptic forms of long-term potentiation at synapses in amygdala. Proc Natl Acad Sci U S A 2010, 107:19073-19078.
84. Tan H., Lauzon N.M., Bishop S.F., Bechard M.A., Laviolette S.R. Integrated cannabinoid CB1 receptor transmission within the amygdala-prefrontal cortical pathway modulates neuronal plasticity and emotional memory encoding. Cereb Cortex 2010, 20:1486-1496.
85. Tan H., Lauzon N.M., Bishop S.F., Chi N., Bechard M., Laviolette S.R. Cannabinoid transmission in the basolateral amygdala modulates fear memory formation via functional inputs to the prelimbic cortex. J Neurosci 2011, 31:5300-5312.
86. Thomas E.A., Cravatt B.F., Danielson P.E., Gilula N.B., Sutcliffe J.G. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J Neurosci Res 1997, 50:1047-1052.
87. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
88. Tsou K., Nogueron M.I., Muthian S., Sanudo-Pena M.C., Hillard C.J., Deutsch D.G., Walker J.M. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 1998, 254:137-140.
89. Uchigashima M., Narushima M., Fukaya M., Katona I., Kano M., Watanabe M. Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci 2007, 27:3663-3676.
90. Ueda N., Tsuboi K., Uyama T. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochim Biophys Acta 2010, 1801:1274-1285.
91. Yoshida T., Uchigashima M., Yamasaki M., Katona I., Yamazaki M., Sakimura K., Kano M., Yoshioka M., Watanabe M. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc Natl Acad Sci U S A 2011, 108:3059-3064.
92. Zarrindast M.R., Sarahroodi S., Arzi A., Khodayar M.J., Taheri-Shalmani S., Rezayof A. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Behav Pharmacol 2008, 19:716-723.
93. Zhu P.J., Lovinger D.M. Retrograde endocannabinoid signaling in a postsynaptic neuron/synaptic bouton preparation from basolateral amygdala. J Neurosci 2005, 25:6199-6207.